An association between parvovirus B19 and Kikuchi-Fujimoto disease

Viral Immunology

Volumn 20, Issue 3, 2007, Pages 421-428

  Zhang, Wei Ping ^a,b   Wang, Juan Hong ^a   Wang, Wen Qing ^a   Chen, Xie Qun ^a   Wang, Zhe ^a   Li, Yuan Fei ^a   Hu, Pei Zhen ^a   Zhang, Wei ^c   Wang, Lu ^a   Wang, Di ^a   Huang, Gao Sheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Urumqi General Hospital   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; VIRUS PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIKUCHI DISEASE; MALE; NONHUMAN; PARVOVIRUS; PARVOVIRUS INFECTION; PATHOGENESIS; POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS GENOME;

ADOLESCENT; ADULT; AGED; CHILD; DNA, VIRAL; FEMALE; HISTIOCYTES; HISTIOCYTIC NECROTIZING LYMPHADENITIS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODES; LYMPHOCYTES; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

PARVOVIRUS;

EID: 35348863955     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.0098     Document Type: Article

References (45)

1. Ali MH, and Horton LW: Necrotising lymphadenitis without granulocytic infiltration (Kikuchi's disease). J Clin Pathol 1985;38:1252-1257.
2. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CL, Cohen BJ, Mortimer PP, and Pereira MS: Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983;1:1378.
3. Atarashi K, Yoshimura N, Nodera H, Tsukimoto K, Beppu H, and Kanayama M: Recurrent histiocytic necrotizing lymphadenitis (Kikuchi's disease) in an human T lymphotropic virus type I carrier. Intern Med 1996;35:821-825.
4. Bosch X, Guilabert A, Miquel R, and Campo E: Enigmatic Kikuchi-Fujimoto disease: A comprehensive review. Am J Clin Pathol 2004;122:141-152.
5. Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, and Young NS: Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994;330:1192-1196.
6. Bultmann BD, Klingel K, Sotlar K, Bock CT, and Kandolf R: Parvovirus B19: A pathogen responsible for more than hematologic disorders. Virchows Arch 2003;442:8-17.
7. Chamulak GA, Brynes RK, and Nathwani BN: Kikuchi-Fujimoto disease mimicking malignant lymphoma. Am J Surg Pathol 1990;14:514-523.
8. Charalabopoulos K, Charalabopoulos A, Binolis J, Papalimneou V, and Ioachim E: Is implant pacemaker a physicochemical cause triggering Kikuchi-Fujimoto disease? In Vivo 2002;16:73-76.
9. Chiu CF, Chow KC, Lin TY, Tsai MH, Shih CM, and Chen LM: Virus infection in patients with histiocytic necrotizing lymphadenitis in Taiwan: Detection of Epstein-Barr virus, type I human T-cell lymphotropic virus, and parvovirus B19. Am J Clin Pathol 2000;113:774-781.
10. Cho KJ, Lee SS, and Khang SK: Histiocytic necrotizing lymphadenitis: A clinico-pathologic study of 45 cases with in situ hybridization for Epstein-Barr virus and hepatitis B virus. J Korean Med Sci 1996;11:409-414.
11. Cohen BJ, and Buckley MM: The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988;25:151-153.
12. Cooling LL, Zhang S, de Naides SJ, and Koerner TA: Glycosphingolipid expression in acute nonlymphocytic leukemia: Common expression of shiga toxin and parvovirus B19 receptors on early myeloblasts. Blood 2003;101:711-721.
13. Cossart YE, Field AM, Cant B, and Widdows D: Parvovirus-like particles in human sera. Lancet 1975;1:72-73.
14. Dorfman RF: Histiocytic necrotizing lymphadenitis of Kikuchi and Fujimoto. Arch Pathol Lab Med 1987;111:1026-1029.
15. Dunstan RA: Status of major red cell blood group antigens on neutrophils, lymphocytes and monocytes. Br J Haematol 1986;62:301-309.
16. Elias JM, Margiotta M, and Gaborc D: Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol 1989;92:62-67.
17. Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A, et al.: PG-M1: A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993;142:1359-1372.
18. Feller AC, Lennert K, Stein H, Bruhn HD, and Wuthe HH: Immunohistology and aetiology of histiocytic necrotizing lymphadenitis: Report of three instructive cases. Histopathology 1983;7:825-839.
19. George TI, Jones CD, Zehnder JL, Warnke RA, and Dorfman RF: Lack of human herpesvirus 8 and Epstein-Barr virus in Kikuchi's histiocytic necrotizing lymphadenitis. Hum Pathol 2003;34:130-135.
20. Greer CE, Peterson SL, Kiviat NB, and Manos MM: PCR amplification from paraffin-embedded tissues: Effects of fixative and fixation time. Am J Clin Pathol 1991;95:117-124.
21. Heikens J, Tel W, van de Stadt J, de Koning J, and ten Napel CH: Kikuchi's lymphadenitis: Report of a Yersinia enterocolitica-associated case and an overview of aetiology and clinical outcome. Neth J Med 1992;41:222-228.
22. Hollingsworth HC, Peiper SC, Weiss LM, Raffeld M, and Jaffe ES: An investigation of the viral pathogenesis of Kikuchi-Fujimoto disease: Lack of evidence for Epstein-Barr virus or human herpesvirus type 6 as the causative agents. Arch Pathol Lab Med 1994;118:134-140.
23. Huh J, Chi HS, Kim SS, and Gong G: A study of the viral etiology of histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease). J Korean Med Sci 1998;13:27-30.
24. Johnson LB, Pasumarthy A, and Saravolatz LD: Parvovirus B19 infection presenting with necrotizing lymphadenitis. Am J Med 2003;114:340-341.
25. Kerr JR, Barah F, Mattey DL, Laing I, Hopkins SJ, Hutchinson IV, and Tyrrell DA: Circulating tumour necrosis factor-α and interferon-γ are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol 2001;82:3011-3019.
26. Kikuchi M, Yoshizumi T, and Nakamura H: Necrotizing lymphadenitis: possible acute toxoplasmic infection. Virchows Arch A Pathol Anat Histol 1977;376:247-253.
27. Koch WC: Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis 2001;14:343-356.
28. Mehraein Y, Lennerz C, Ehlhardt S, Venzke T, Ojak A, Remberger K, and Zang KD: Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis. Mod Pathol 2003;16:811-817.
29. Menasce LP, Banerjee SS, Edmondson D, and Harris M: Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): Continuing diagnostic difficulties. Histopathology 1998;33:248-254.
30. Meyer O, Kahn MF, Grossin M, Ribard P, Belmatoug N, Morinet F, and Fournet JC: Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus. Lupus 1991;1:37-41.
31. Mitchell LA: Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: Common pathway in inflammatory sequelae of human parvovirus infections? J Med Virol 2002;67:267-274.
32. Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O, Hirano T, and Sugamura K: A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 1996;70:8485-8491.
33. Morey AL, Porter HJ, Keeling JW, and Fleming KA: Nonisotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection. J Clin Pathol 1992;45:673-678.
34. Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, and Roizman B: Infectious agents and cancer: Criteria for a causal relation. Semin Cancer Biol 2004;14:453-471.
35. Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE, and Murtaza L: Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981;1:664-665.
36. Sever CE, Leith CP, Appenzeller J, and Foucar K: Kikuchi's histiocytic necrotizing lymphadenitis associated with ruptured silicone breast implant. Arch Pathol Lab Med 1996;120:380-385.
37. Shirono K, and Tsuda H: Parvovirus B19-associated haemophagocytic syndrome in healthy adults. Br J Haematol 1995;89:923-926.
38. Soloninka CA, Anderson MJ, and Laskin CA: Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19. J Rheumatol 1989;16:777-781.
39. Sumiyoshi Y, Kikuchi M, Minematu T, Ohshima K, Takeshita M, and Minamishima Y: Analysis of herpesvirus genomes in Kikuchi's disease. Virchows Arch 1994;424:437-440.
40. Sumiyoshi Y, Kikuchi M, Ohshima K, Yoneda S, Kobari S, Takeshita M, Eizuru Y, and Minamishima Y: Human herpesvirus-6 genomes in histiocytic necrotizing lymphadenitis (Kikuchi's disease) and other forms of lymphadenitis. Am J Clin Pathol 1993;99:609-614.
41. Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, Saitoh T, Sawai T, Sugamura K, and Sasaki T: Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998;95:8227-8232.
42. Walters C, Powe DG, Padfield CJ, and Fagan DG: Detection of parvovirus B19 in macerated fetal tissue using in situ hybridisation. J Clin Pathol 1997;50:749-754.
43. Yen A, Fearneyhough P, Raimer SS, and Hudnall SD: EBV-associated Kikuchi's histiocytic necrotizing lymphadenitis with cutaneous manifestations. J Am Acad Dermatol 1997;36:342-346.
44. Young NS, and Brown KE: Parvovirus B19. N Engl J Med 2004;350:586-597.
45. Yufu Y, Matsumoto M, Miyamura T, Nishimura J, Nawata H, and Ohshima K: Parvovirus B19-associated haemophagocytic syndrome with lymphadenopathy resembling histiocytic necrotizing lymphadenitis (Kikuchi's disease). Br J Haematol 1997;96:868-871.